BackAspire Biopharma Holdings Overview

Aspire Biopharma Holdings Net Tangible Assets

Aspire Biopharma Holdings's net tangible assets is $3.9M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$3.87M

Peer average

Loading

Aspire Biopharma Holdings Net Tangible Assets History

Loading

Aspire Biopharma Holdings vs. peers: Net Tangible Assets Comparison

Loading

Aspire Biopharma Holdings Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Aspire Biopharma Holdings (ASBP) FAQ

As of the most recent data (March 2026), ASBP shows a net tangible assets of $3.9M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASBP's net tangible assets is now $3.9M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Aspire Biopharma Holdings is outperforming or lagging.

Tracking ASBP's net tangible assets over time shows whether Aspire Biopharma Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $3.9M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Aspire Biopharma Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $3.9M) with ownership activity and broader fundamentals.